<p>India said it will administer homegrown coronavirus vaccine Covaxin in seven more states from Monday as it seeks to inoculate 30 million healthcare workers across the country.</p>.<p>The government this month gave emergency-use approval to the vaccine, developed by Bharat Biotech International Ltd and state-run Indian Council of Medical Research, and another licensed from Oxford University and AstraZeneca PLC that is being manufactured by the Serum Institute of India.</p>.<p>The expansion from the 12 states now administering Covaxin includes the southern state of Kerala, which has a high Covid-19 caseload, and Prime Minister Narendra Modi's home state of Gujarat, the government said late on Saturday.</p>.<p><strong>Read | <a href="https://www.deccanherald.com/national/one-million-covid-19-vaccine-doses-administered-in-india-in-just-6-days-health-ministry-942745.html" target="_blank">One million Covid-19 vaccine doses administered in India in just 6 days: Health ministry</a></strong></p>.<p>Some doctors have expressed doubt about Covaxin, which was approved without efficacy data from late-stage clinical trials. The government says it is safe. The Lancet medical journal said on Thursday the drug produced an immune response in a small group of adults.</p>.<p>Authorities have inoculated nearly 1.6 million health workers overall using the two vaccines, the government said on Sunday.</p>.<p>India is also exporting doses, including commercial shipments to Brazil and Morocco, and free shipments to the Maldives, Bhutan, Bangladesh and Nepal.</p>.<p>India recently trained immunisation-programme managers from 13 foreign countries using Indian vaccines, the government said.</p>.<p>With 1.35 billion people, India has reported 10.65 million coronavirus infections - the highest after the United States - with 153,339 Covid-19 deaths.</p>.<p>The vaccination drive, targeting frontline workers, is to be expanded later to cover 270 million people older than 50 or deemed at high risk because of pre-existing medical conditions.</p>
<p>India said it will administer homegrown coronavirus vaccine Covaxin in seven more states from Monday as it seeks to inoculate 30 million healthcare workers across the country.</p>.<p>The government this month gave emergency-use approval to the vaccine, developed by Bharat Biotech International Ltd and state-run Indian Council of Medical Research, and another licensed from Oxford University and AstraZeneca PLC that is being manufactured by the Serum Institute of India.</p>.<p>The expansion from the 12 states now administering Covaxin includes the southern state of Kerala, which has a high Covid-19 caseload, and Prime Minister Narendra Modi's home state of Gujarat, the government said late on Saturday.</p>.<p><strong>Read | <a href="https://www.deccanherald.com/national/one-million-covid-19-vaccine-doses-administered-in-india-in-just-6-days-health-ministry-942745.html" target="_blank">One million Covid-19 vaccine doses administered in India in just 6 days: Health ministry</a></strong></p>.<p>Some doctors have expressed doubt about Covaxin, which was approved without efficacy data from late-stage clinical trials. The government says it is safe. The Lancet medical journal said on Thursday the drug produced an immune response in a small group of adults.</p>.<p>Authorities have inoculated nearly 1.6 million health workers overall using the two vaccines, the government said on Sunday.</p>.<p>India is also exporting doses, including commercial shipments to Brazil and Morocco, and free shipments to the Maldives, Bhutan, Bangladesh and Nepal.</p>.<p>India recently trained immunisation-programme managers from 13 foreign countries using Indian vaccines, the government said.</p>.<p>With 1.35 billion people, India has reported 10.65 million coronavirus infections - the highest after the United States - with 153,339 Covid-19 deaths.</p>.<p>The vaccination drive, targeting frontline workers, is to be expanded later to cover 270 million people older than 50 or deemed at high risk because of pre-existing medical conditions.</p>